Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing

Nature Genetics

Volumn 37, Issue 3, 2005, Pages 254-264

  Harikrishnan, K N ^a   Chow, Maggie Z ^a   Baker, Emma K ^a   Pal, Sharmistha ^b   Bassal, Sahar ^a   Brasacchio, Daniella ^a   Wang, Li ^b   Craig, Jeff M ^c   Jones, Peter L ^d   Sif, Saïd ^b   El Osta, Assam ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b OHIO STATE UNIVERSITY   (United States)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BRM; PROTEIN SWI; REGULATOR PROTEIN; UNCLASSIFIED DRUG; BRM PROTEIN, DROSOPHILA; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DROSOPHILA PROTEIN; FMR1 PROTEIN, HUMAN; FMR1 PROTEIN, MOUSE; FRAGILE X MENTAL RETARDATION PROTEIN; HISTONE; MECP2 PROTEIN, HUMAN; MECP2 PROTEIN, MOUSE; NERVE PROTEIN; NONHISTONE PROTEIN; REPRESSOR PROTEIN; RNA BINDING PROTEIN; SWI SNF B CHROMATIN REMODELING COMPLEX; SWI-SNF-B CHROMATIN-REMODELING COMPLEX; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA METHYLATION; FRAGILE X SYNDROME; GENE SILENCING; IMMUNOPRECIPITATION; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ANIMAL; CELL STRAIN 3T3; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CELL CYCLE PROTEINS; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; FRAGILE X MENTAL RETARDATION PROTEIN; GENE SILENCING; HISTONES; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; REPRESSOR PROTEINS; RNA-BINDING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 20144379888     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1516     Document Type: Article

References (50)

1. El-Osta, A. & Wolffe, A.P. DNA methylation and historic deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr. 9, 63-75 (2000).
2. Meehan, R.R., Lewis, J.D., Mckay, S., Kleiner, E.L. & Bird, A.P. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58, 499-507 (1989).
3. Jones, P.L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19, 187-191 (1998).
4. Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
5. Bird, A.P. & Wolffe, A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454 (1999).
6. Fuks, F. et al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278, 4035-4040 (2003).
7. Kimura, H. & Shiota, K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem. 278, 4806-4812 (2003).
8. Narlikar, G.J., Fan, H.Y. & Kingston, R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487 (2002).
9. Peterson, C.L. & Workman, J.L. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 10, 187-192 (2000).
10. Wang, W. et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15, 5370-5382 (1996).
11. Wang, W. et al. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 10, 2117-2130 (1996).
12. Martens, J.A. & Winston, F. Evidence that Swi/Snf directly represses transcription in S. cerevisiae. Genes Dev. 16, 2231-2236 (2002).
13. Tong, J.K., Hassig, C.A., Schnitzler, G.R., Kingston, R.E. & Schreiber, S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395, 917-921 (1998).
14. Sif, S., Saurin, AJ., Imbalzano, A.N. & Kingston, R.E. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev. 15, 603-618 (2001).
15. Bowen, N.J., Fujita, N., Kajita, M. & Wade, P.A. Mi-2/NuRD: multiple complexes for many purposes. Biochim. Biophys. Acta 1677, 52-57 (2004).
16. El-Osta, A., Kantharidis, P., Zalcberg, J.R. & Wolffe, A.P. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol. 22, 1844-1857 (2002).
17. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. & Baylin, S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21, 103-107 (1999).
18. Coffee, B., Zhang, F., Warren, ST. & Reines, D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22, 98-101 (1999).
19. Magdinier, F. & Wolffe, A.P. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. USA 98, 4990-4995 (2001).
20. Nguyen, C.T., Gonzales, F.A. & Jones, P.A. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 29, 4598-4606 (2001).
21. Ballestar, E. et al. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22, 6335-6345 (2003).
22. Pal, S. et al. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol. Cell. Biol. 23, 7475-7487 (2003).
23. El-Osta, A., Baker, E.K. & Wolffe, A.P. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin. Mol. Biol. Rep. 28, 209-215 (2001).
24. Li, Q., Ahuja, N., Burger, P.C. & Issa, J.P. Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene 18, 3284-3289 (1999).
25. Hannon, G.J. RNA interference. Nature 418, 244-251 (2002).
26. Jin, P. & Warren, S.T. Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 9, 901-908 (2000).
27. Oberle, I. et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102 (1991).
28. Kremer, E.J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711-1714 (1991).
29. Verheij, C. et al. Characterization of FMR1 proteins isolated from different tissues. Hum. Mol. Genet. 4, 895-901 (1995).
30. Klose, R.J. & Bird, A.P. MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J. Biol. Chem. 279, 46490-46496 (2004).
31. Battaglioli, E. et al. REST repression of neuronal genes requires components of the hSWI.SNF complex. J. Biol. Chem. 277, 41038-41045 (2002).
32. Kass, S.U., Landsberger, N. & Wolffe, A.P. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7, 157-165 (1997).
33. Flaus, A. & Owen-Hughes, T. Dynamic properties of nucleosomes during thermal and ATP-driven mobilization. Mol. Cell. Biol. 23, 7767-7779 (2003).
34. Fyodorov, D.V., Blower, M.D., Karpen, G.H. & Kadonaga, J.T. Acf1 confers unique activities to ACF/CHRAC and promotes the formation rather than disruption of chromatin in vivo. Genes Dev. 18, 170-183 (2004).
35. Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nat. Genet. 21, 163-167 (1999).
36. Di, C.L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079-1082 (2002).
37. Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556 (2002).
38. Godde, J.S., Kass, S.U., Hirst, M.C. & Wolffe, A.P. Nucleosome assembly on methylated CGG triplet repeats in the fragile X mental retardation gene 1 promoter. J. Biol. Chem. 271, 24325-24328 (1996).
39. Sutcliffe, J.S. et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1, 397-400 (1992).
40. Coffee, B., Zhang, F., Ceman, S., Warren, S.T. & Reines, D. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am. J. Hum. Genet. 71, 923-932 (2002).
41. Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V.A. & Bird, A. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15, 710-723 (2001).
42. Wade, P.A. et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23, 62-66 (1999).
43. Zhang, Y. et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935 (1999).
44. Damelin, M. et al. The genome-wide localization of Rsc9, a component of the RSC chromatin-remodeling complex, changes in response to stress. Mol. Cell 9, 563-573 (2002).
45. Ng, H.H., Robert, F., Young, R.A. & Struhl, K. Genome-wide location and regulated recruitment of the RSC nucleosome-remodeling complex. Genes Dev. 16, 806-819 (2002).
46. Goldmark, J.P., Fazzio, T.G., Estep, P.W., Church, G.M. & Tsukiyama, T. The Isw2 chromatin remodeling complex represses early meiotic genes upon recruitment by Ume6p. Cell 103, 423-433 (2000).
47. Martens, J.A., Laprade, L. & Winston, F. Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature 429, 571-574 (2004).
48. Valerius, O., Brendel, C., Duvel, K. & Braus, G.H. Multiple factors prevent transcriptional interference at the yeast AR04-HIS7 locus. J. Biol. Chem. 277, 21440-21445 (2002).
49. Wheatley, S.P., Carvalho, A., Vagnarelli, P. & Earnshaw, W.C. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 11, 886-890 (2001).
50. El-Osta, A. & Wolffe, A.P. Analysis of chromatin-immunopurified MeCP2-associated fragments. Biochem. Biophys. Res. Commun. 289, 733-737 (2001).